The most notable survival associations were seen for expression of TAS2R14 in adrenocortical carcinoma, esophageal adenocarcinoma, and non-papillary bladder cancer which were significant based on analysis of mean survival difference and Kaplan–Meier analysis. The gene discussed is TAS2R14; the disease is adrenal cortex carcinoma.